UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Prevalence of hepatitis C virus infection in patients with COPD

Epidemiology and infection, 2010-02, Vol.138 (2), p.167-173

2010

Volltextzugriff (PDF)

Impact of age on viral kinetics of peginterferon alfa-2a/ribavirin in chronic hepatitis C: final analysis from the PROPHESYS cohort

Journal of viral hepatitis, 2014-05, Vol.21 (5), p.377-380

2014

Volltextzugriff (PDF)

Results of up to 2 years of entecavir vs lamivudine therapy in nucleoside-naïve HBeAg-positive patients with chronic hepatitis B

Journal of viral hepatitis, 2009-11, Vol.16 (11), p.784-789

2009

Volltextzugriff (PDF)

Entecavir versus Lamivudine for Patients with HBeAg-Negative Chronic Hepatitis B

The New England journal of medicine, 2006-03, Vol.354 (10), p.1011-1020

2006

Volltextzugriff (PDF)

Cost-effectiveness of combination peginterferon alpha-2a and ribavirin compared with interferon alpha-2b and ribavirin in patients with chronic hepatitis C

The American journal of gastroenterology, 2004-08, Vol.99 (8), p.1490-1496

2004

Volltextzugriff (PDF)

Peginterferon alfa-2a (40KD) (PEGASYS) plus ribavirin (COPEGUS) in retreatment of chronic hepatitis C patients, nonresponders and relapsers to previous conventional interferon plus ribavirin therapy

The Brazilian journal of infectious diseases, 2006-02, Vol.10 (1), p.11-16

2006

Volltextzugriff (PDF)

Entecavir therapy for lamivudine‐refractory chronic hepatitis B: Improved virologic, biochemical, and serology outcomes through 96 weeks

Hepatology (Baltimore, Md.), 2008-07, Vol.48 (1), p.99-108

2008

Volltextzugriff (PDF)

Hepatitis C virus genotypes in Southern Brazil

Brazilian journal of medical and biological research, 1996-12, Vol.29 (12), p.1629

1996

Volltextzugriff (PDF)

Intranasal cocaine use does not appear to be an independent risk factor for HCV infection

Addiction (Abingdon, England), 2004-08, Vol.99 (8), p.973-977

2004

Volltextzugriff (PDF)

Procollagen-III peptide and chronic viral C hepatitis

The American journal of gastroenterology, 1995-09, Vol.90 (9), p.1437-1440

1995

Volltextzugriff (PDF)

Viral pathogenesis of hepatocellular carcinoma in the United States

Hepatology (Baltimore, Md.), 1993-12, Vol.18 (6), p.1326-1333

1993

Volltextzugriff (PDF)

Detection of hepatitis C virus antibody by first and second generation assays and polymerase chain reaction in patients with autoimmune chronic active hepatitis types I, II, and III

The American journal of gastroenterology, 1993-07, Vol.88 (7), p.1027-1034

1993

Volltextzugriff (PDF)

Fulminant or subfulminant non-A, non-B viral hepatitis: The role of hepatitis C and E viruses

Gastroenterology (New York, N.Y. 1943), 1993-02, Vol.104 (2), p.556-562

1993

Volltextzugriff (PDF)

Role of hepatic hemodynamic study in the evaluation of patients with cirrhosis

Hepato-gastroenterology, 2003-11, Vol.50 (54), p.2052

2003

Volltextzugriff (PDF)

Laparoscopic and histologic findings in patients with the human immunodeficiency virus

Gastrointestinal endoscopy, 1994-03, Vol.40 (2), p.160-164

1994

Volltextzugriff (PDF)

Treatment of Chronic HCV Infection with the New Direct Acting Antivirals (DAA): First Report of a Real World Experience in Southern Brazil

Annals of hepatology, 2017-09, Vol.16 (5), p.727-733

2017

Volltextzugriff (PDF)

Effect of sustained virologic response on the incidence of hepatocellular carcinoma in patients with HCV cirrhosis

The Brazilian journal of infectious diseases, 2010-09, Vol.14 (5), p.457-461

2010

Volltextzugriff (PDF)

1 – 17 von 17

Suche als RSS-Feed

Aktive Filter

KollektionMEDLINE

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(17)
Mit Volltextzugriff
(12)

Publikationsform

Artikel
(17)

Sprache

Englisch
(17)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Prevalence of hepatitis C virus infection in patients with COPD

Impact of age on viral kinetics of peginterferon alfa-2a/ribavirin in chronic hepatitis C: final analysis from the PROPHESYS cohort

Results of up to 2 years of entecavir vs lamivudine therapy in nucleoside-naïve HBeAg-positive patients with chronic hepatitis B

Entecavir versus Lamivudine for Patients with HBeAg-Negative Chronic Hepatitis B

Cost-effectiveness of combination peginterferon alpha-2a and ribavirin compared with interferon alpha-2b and ribavirin in patients with chronic hepatitis C

Peginterferon alfa-2a (40KD) (PEGASYS) plus ribavirin (COPEGUS) in retreatment of chronic hepatitis C patients, nonresponders and relapsers to previous conventional interferon plus ribavirin therapy

Entecavir therapy for lamivudine‐refractory chronic hepatitis B: Improved virologic, biochemical, and serology outcomes through 96 weeks

Hepatitis C virus genotypes in Southern Brazil

Intranasal cocaine use does not appear to be an independent risk factor for HCV infection

Procollagen-III peptide and chronic viral C hepatitis

Viral pathogenesis of hepatocellular carcinoma in the United States

Detection of hepatitis C virus antibody by first and second generation assays and polymerase chain reaction in patients with autoimmune chronic active hepatitis types I, II, and III

Fulminant or subfulminant non-A, non-B viral hepatitis: The role of hepatitis C and E viruses

Role of hepatic hemodynamic study in the evaluation of patients with cirrhosis

Laparoscopic and histologic findings in patients with the human immunodeficiency virus

Treatment of Chronic HCV Infection with the New Direct Acting Antivirals (DAA): First Report of a Real World Experience in Southern Brazil

Effect of sustained virologic response on the incidence of hepatocellular carcinoma in patients with HCV cirrhosis

Aktive Filter

Suchergebnisse filtern